ArticleJournal of chemical information and modeling2025
PairMap: An Intermediate Insertion Approach for Improving the Accuracy of Relative Free Energy Perturbation Calculations for Distant Compound Transformations.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- PairMap2: A Web Application for Intermediate-Molecule Insertion in Relative Binding Free Energy Calculations.Molecular informatics · 2026Article
- Benchmarking HelixFold3-Predicted Holo Structures for Relative Free Energy Perturbation Calculations.ACS omega · 2025Article
- IMERGE-FEP: Improving Relative Free Energy Calculation Convergence with Chemical Intermediates.The journal of physical chemistry. B · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of the difference in binding free energy between compounds is crucial for reducing the high costs associated with drug discovery. Relative binding free energy perturbation (RBFEP) calculations are effective for small structural changes; however, large topological changes pose significant challenges for calculations, leading to high errors and difficulties in convergence. To address such issues, we propose a new approach─PairMap─that focuses on introducing appropriate intermediates for complex transformations between two input compounds. PairMap-generated intermediates exhaustively, determined the optimal conversion paths, and introduced thermodynamic cycles into the perturbation map to improve accuracy and reduce computational cost. PairMap succeeded in introducing appropriate intermediates that could not be discovered by existing simple approaches by comprehensively considering intermediates. Furthermore, we evaluated the accuracy of the prediction of binding free energy using 9 compounds selected from Wang et al.'s benchmark set, which included particularly complex transformations. The perturbation map generated by PairMap achieved excellent accuracy with a mean absolute error of 0.93 kcal/mol compared to 1.70 kcal/mol when using the perturbation map generated by the conventional Flare FEP intermediate introduction method. Moreover, in a scaffold hopping experiment conducted with the PDE5a target involving complex transformations, PairMap provided more accurate free energy predictions than ABFEP calculations, yielding more reliable results compared to experimental data. Additionally, PairMap can be utilized to introduce intermediates into congeneric series, demonstrating that complex links on the perturbation map can be resolved with minimal addition of intermediates and links. In conclusion, PairMap overcomes the limitations of existing methods by enabling RBFEP calculations for more complex transformations, further streamlining lead optimization in drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.